A detailed history of Ahrens Investment Partners LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Ahrens Investment Partners LLC holds 226 shares of NVO stock, worth $19,745. This represents 0.02% of its overall portfolio holdings.

Number of Shares
226
Holding current value
$19,745
% of portfolio
0.02%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

Apr 21, 2023

BUY
$132.34 - $159.14 $29,908 - $35,965
226 New
226 $35,000
Q4 2021

Jan 21, 2022

BUY
$95.88 - $117.08 $21,668 - $26,460
226 New
226 $25,000

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $197B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Ahrens Investment Partners LLC Portfolio

Follow Ahrens Investment Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ahrens Investment Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ahrens Investment Partners LLC with notifications on news.